Soldiers acquired drug-resistant infections in field hospitals

An outbreak of drug-resistant wound infections among soldiers in Iraq likely came from the hospitals where they were treated, not the battlefield, according to a new study in the June 15 issue of Clinical Infectious Diseases, currently available online.

The outbreak of drug-resistant Acinetobacter baumannii-calcoaceticus complex (ABC) infections among U.S. service members injured in Iraq has been of major concern to military health care workers since it was first detected in 2003. ABC bacteria are commonly found in soil and water. They sometimes also exist on the skin of healthy people. The bacteria pose little risk to healthy people. However, those with open wounds or weakened immune systems are at greater risk of ABC infection. An ABC infection can cause or contribute to death, especially if the patient is immunosuppressed.

Historically, ABC infections were treated with a wide variety of drugs. Unfortunately, in recent years, strains of Acinetobacter have been emerging that are resistant to nearly all known remedies. The ABC infections found among the U.S. service members are of this type, known as multi-drug resistant (MDR).

Between March and October 2003, researchers from the Army and the Centers for Disease Control and Prevention identified 145 inpatients at U.S. military treatment facilities infected or colonized with ABC. The researchers attempted to identify the source(s) of the outbreak. They tested for the presence of ABC on the skin of casualties treated in or evacuated from Iraq. They tested soil samples taken near field hospitals in Iraq and from locations throughout Iraq and Kuwait. And they looked at samples taken from in and around patient-treatment areas in five field hospitals in Iraq and two in Kuwait.

They found ABC in only one out of 49 soil samples and just one out of 160 samples from soldiers skin. By contrast, ABC organisms were found in the patient treatment areas of all seven field hospitals sampl

Contact: Steve Baragona
Infectious Diseases Society of America

Page: 1 2

Related medicine news :

1. New contracts support clinical trials on antibiotic-resistant, community-acquired staph infections
2. Hospital-acquired infections -- Inevitable?
3. Study indicates dramatic rise in antibiotic-resistant community-acquired staph infections
4. Scientists uncover genes for virulence in strain of community-acquired MRSA
5. PlasmaSol, Stevens spin-out, acquired for $17.5 million
6. Heart burn medication a risk factor for community-acquired C. difficile
7. Chest x-rays not effective in determining when TB acquired
8. Nepalese researchers identify cost-effective treatment for drug-resistant typhoid
9. US soldiers in Iraq fighting drug-resistant bacteria after injuries
10. Wrapping Gleevec fights drug-resistant cancer
11. New research may overturn conventional wisdom on drug-resistant tuberculosis

Post Your Comments:

(Date:11/27/2015)... ... November 27, 2015 , ... ... convenient way to dispense prescription medications at home, so he invented the patent-pending ... monitor and dispense prescription medications. In doing so, it could help to prevent ...
(Date:11/27/2015)... ... 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% ... More than 3.7 billion people under the age of 50 – or 67% of the ... first global estimates of HSV-1 infection . , "The data shocks us highly!" said ...
(Date:11/27/2015)... ... November 27, 2015 , ... Keeping in mind challenges ... health and wellness consultation, has collaborated with a leading web-based marketplace for extra-curricular ... experienced by parents and bring advice from parenting experts within their reach. As ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft ... announces the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite ... LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive ...
(Date:11/26/2015)... ... 2015 , ... The Catalent Applied Drug Delivery Institute today ... dose form selection in early phase drug development. The first of these is ... together the UK’s emerging life sciences companies, corporate partners, and investors, at Milton ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... "Self Administration of High Viscosity Drugs" ... ) has announced the addition of the ... to their offering. --> Research and ... of the "Self Administration of High Viscosity ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the European Cell Surface Marker Testing ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/25/2015)... 25, 2015  Amgen (NASDAQ: AMGN ) today ... with the United States (U.S.) ... biosimilar candidate to Humira ® (adalimumab). Amgen believes ... to the FDA and represents Amgen,s first BLA submission ... Harper , M.D., executive vice president of Research and ...
Breaking Medicine Technology:
Cached News: